Repurposed membrane-targeting RS17053 eradicates MRSA persisters and enhances aminoglycoside killing.

The rapid rise of methicillin-resistant Staphylococcus aureus (MRSA) and its ability to form antibiotic-tolerant persisters pose a major challenge to antimicrobial therapy. These metabolically dormant cells survive antibiotic exposure without genetic resistance, driving chronic and relapsing infections. Here, we characterize RS17053-a selective α1A-adrenoceptor antagonist- as a membrane-active compound with potent activity against both antibiotic-resistant and antibiotic-tolerant S. aureus. RS17053 disrupts bacterial phospholipid bilayers, causing membrane permeabilization, intracellular leakage, accumulation of reactive oxygen species, and subsequent cell death, while exhibiting minimal cytotoxicity toward mammalian cells. The compound shows no detectable resistance after prolonged exposure and synergistically enhances aminoglycoside potency by promoting drug uptake into MRSA persisters. In a Caenorhabditis elegans infection model, RS17053 protects hosts from lethal MRSA challenge. Collectively, these findings support RS17053 as an antimicrobial lead compound suitable for repurposing as both a direct-acting antimicrobial and an adjuvant to aminoglycosides for treating persistent MRSA infections.

• Publication year

  2025

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  2025-11-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.biopha.2025.118763PMID 41218340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unfolding the Potential of Pyrrole- and Indole-Based Allylidene Hydrazine Carboximidamides as Antimicrobial Agents.

  2025cited by this paper
• Local enhancement of cationic charge density via polyamine side chain incorporation improves the selectivity of antimicrobial peptoids.

  2025cited by this paper
• Heavy metals promote the formation of multidrug-tolerant Staphylococcus aureus and Escherichia coli persisters.

  2025cited by this paper
• Novel membrane-targeting isoxanthohumol-amine conjugates for combating methicillin-resistant Staphylococcus aureus (MRSA) infections.

  2024cited by this paper
• Synthetic indole derivatives as an antibacterial agent inhibiting respiratory metabolism of multidrug-resistant gram-positive bacteria

  2024cited by this paper
• Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

  2024cited by this paper
• Bacterial persisters: molecular mechanisms and therapeutic development

  2024cited by this paper
• Staphylococcus aureus Small-Colony Variants from Airways of Adult Cystic Fibrosis Patients as Precursors of Adaptive Antibiotic-Resistant Mutations

  2023cited by this paper
• A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin

  2023cited by this paper
• Stimulation of Hemolysis and Eryptosis by α-Mangostin through Rac1 GTPase and Oxidative Injury in Human Red Blood Cells

  2023cited by this paper
• Effects of RS17053 on α1‐adrenoceptors in rat vas deferens and aorta

  2023cited by this paper
• Antimicrobial activity of the membrane-active compound nTZDpa is enhanced at low pH.

  2022cited by this paper
• Intracellular Staphylococcus aureus persisters upon antibiotic exposure

  2020cited by this paper
• Evolution of Multi-Resistance to Vancomycin, Daptomycin, and Linezolid in Methicillin-Resistant Staphylococcus aureus Causing Persistent Bacteremia

  2020cited by this paper
• The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus

  2020cited by this paper
• The role of reactive oxygen species in the biological activity of antimicrobial agents: An updated mini review.

  2020cited by this paper
• A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus

  2019cited by this paper
• Discovery and Optimization of nTZDpa as an Antibiotic Effective Against Bacterial Persisters.

  2018cited by this paper
• Methicillin-resistant Staphylococcus aureus

  2018cited by this paper
• A new class of synthetic retinoid antibiotics effective against bacterial persisters

  2018cited by this paper
• Antibacterial Diamines Targeting Bacterial Membranes.

  2016cited by this paper
• Molecular mechanisms of membrane targeting antibiotics.

  2016cited by this paper
• The C. elegans model in toxicity testing

  2016cited by this paper
• Persister formation in Staphylococcus aureus is associated with ATP depletion

  2016cited by this paper
• NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption.

  2016cited by this paper
• Membrane‐Active Small Molecules: Designs Inspired by Antimicrobial Peptides

  2015cited by this paper
• Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics

  2014cited by this paper
• Interaction of Daptomycin with Lipid Bilayers: A Lipid Extracting Effect

  2014cited by this paper
• When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing

  2014cited by this paper
• Staphylococcus aureus Persisters Tolerant to Bactericidal Antibiotics

  2012cited by this paper
• Metabolite-Enabled Eradication of Bacterial Persisters by Aminoglycosides

  2011cited by this paper
• Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections

  2010cited by this paper
• Membrane lipids: where they are and how they behave

  2008cited by this paper
• Methicillin resistant Staphylococcus aureus.

  2006cited by this paper
• Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use

  2005cited by this paper
• Caenorhabditis elegans as a Model Host for Staphylococcus aureus Pathogenesis

  2003cited by this paper
• Search for New Drugs for Treatment of Tuberculosis

  2001cited by this paper
• Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria

  2000cited by this paper
• Aminoglycosides: Nephrotoxicity

  1999cited by this paper
• Effects of the alpha 1a-adrenoceptor antagonist RS-17053 on phenylpropanolamine-induced anorexia in rats.

  1997cited by this paper
• Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli.

  1982cited by this paper

• No citing papers are available for this paper.